Yasutomi D, Odaka C, Saito S, Niizeki H, Kizaki H, Tadakuma T
Department of Microbiology, Keio University School of Medicine, Tokyo, Japan.
Immunology. 1992 Sep;77(1):68-74.
Cyclosporin A (CsA) is reported to inhibit programmed cell death. We confirmed this by using T-cell hybridomas which are inducible to programmed cell death by activation with immobilized anti-CD3 antibody or with anti-Thy 1.2 antibody. Cell death and DNA fragmentation, characteristic features of programmed cell death, were almost completely blocked by CsA or FK506. To investigate whether CsA inhibits only the cell death through the signals via the TCR/CD3 complex or all of the programmed cell death induced by various reagents, we further established CD4+8+ thymic lymphomas which result in programmed cell death after activation with calcium ionophore, dexamethasone, cyclic AMP or anti-CD3 antibody. It was revealed that CsA could block only the cell death mediated by the TCR/CD3 complex. For the clarification of the site of action of CsA, Ca2+ influx and endocytosis of receptors after stimulation with anti-CD3 antibody were monitored in the presence of CsA, and no significant effects of CsA were observed. Furthermore, prevention of cell death was examined by adding CsA at various periods of time after initiation of culture. CsA was found to exert its effect even when added after 4 h of cultivation, and the kinetic pattern of suppression was similar to that of the suppressive effect on IL-2 production. These observations indicate that in the events of programmed cell death, the major site of action of CsA will not be the inhibition of the immediate membrane events after activation of the TCR/CD3 complex but rather the interference in the function of molecules that transmit signals between membrane events and the activation of genes in the nucleus.
据报道,环孢素A(CsA)可抑制程序性细胞死亡。我们通过使用T细胞杂交瘤证实了这一点,这些T细胞杂交瘤在用固定化抗CD3抗体或抗Thy 1.2抗体激活后可诱导程序性细胞死亡。程序性细胞死亡的特征性表现,即细胞死亡和DNA片段化,几乎完全被CsA或FK506阻断。为了研究CsA是否仅通过TCR/CD3复合物的信号抑制细胞死亡,还是抑制由各种试剂诱导的所有程序性细胞死亡,我们进一步建立了CD4+8+胸腺淋巴瘤,这些淋巴瘤在用钙离子载体、地塞米松、环磷酸腺苷或抗CD3抗体激活后会导致程序性细胞死亡。结果显示,CsA只能阻断由TCR/CD3复合物介导的细胞死亡。为了阐明CsA的作用位点,在存在CsA的情况下监测了抗CD3抗体刺激后受体的Ca2+内流和内吞作用,未观察到CsA有显著影响。此外,在培养开始后的不同时间段添加CsA来检测对细胞死亡的预防作用。发现即使在培养4小时后添加CsA仍能发挥作用,其抑制动力学模式与对白细胞介素-2产生的抑制作用相似。这些观察结果表明,在程序性细胞死亡过程中,CsA的主要作用位点不是抑制TCR/CD3复合物激活后的即时膜事件,而是干扰在膜事件与细胞核内基因激活之间传递信号的分子功能。